$0.2749
-0.0041-1.47%
Last update: Nov 11, 7:28 AM
Xtant Medical Holdings Inc
XTNTAMEX
Xtant Medical fell 63.7% from $0.76 to $0.27, behind the S&P 500's +9.8%. Its worst day was Aug 11 (−28.3%), and its low came Nov 10 at $0.27.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Xtant Medical shares rose 14.9%, while the S&P 500 fell 0.3%.
+14.9% · S&P 500 −0.3%
Xtant Medical closed at its highest level of the year, 7.1% above where the year started.
+5.2% · S&P 500 +0.6%
Story events cover the past 12 months · Times ET
EPS of $0.00 beat the $-0.01 estimate on $32.4M revenue (est. $30.8M); FY revenue guidance of $95.0M–$99.0M against the $110.1M consensus.
+2.8% · S&P 500 +2.9%
EPS of $-0.02 beat the $-0.02 estimate on $20.9M revenue (est. $19.8M); FY revenue guidance of $101.0M–$105.0M against the $97.3M consensus.
−4.8% · S&P 500 +0.6%
Xtant Medical shares rose 12.4%, while the S&P 500 rose 0.4%.
+12.4% · S&P 500 +0.4%
EPS of $-0.03 missed the $-0.02 estimate on $23.0M revenue (est. $24.9M); FY revenue guidance of $99.0M–$103.0M against the $102.1M consensus.
−28.3%, the year's worst day · S&P 500 −0.3%
Xtant Medical shares rose 16.4%, while the S&P 500 fell 0.2%.
+16.4%, the year's best day, on 78M shares, the year's heaviest volume · S&P 500 −0.2%
Xtant Medical shares fell 11.1%, while the S&P 500 fell 0.5%.
−11.1% · S&P 500 −0.5%
Where it ended: a close of $0.27 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 16, 2026 (EPS est. $-0.02, revenue est. $25.5M).
Nothing in the past 12 months.
All XTNT dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for XTNT and SPY from Benzinga historical bars. Not investment advice.
